Dengue Testing Market Size, Latest Trends, Industry Statistics Report 2023-2028

IMARC Group, a leading market research company, has recently releases a report titled "Dengue Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big is the Dengue Testing Market?

The global dengue testing market size reached US$ 555.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 761.6 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.

Request a PDF Sample for more detailed market insights: https://www.imarcgroup.com/dengue-testing-market/requestsample

Dengue testing is utilized to diagnose dengue fever, which is a virus spread by mosquitoes. It is primarily available in two types, including molecular tests like polymerase chain reaction (PCR) and serological tests like enzyme-linked immunosorbent assay (ELISA) identify antibodies generated in response to the infection. It facilitates early detection, allowing for prompt medical attention and lowering the possibility of consequences like dengue hemorrhagic fever. It offers a precise diagnosis that avoids mishandling, such as giving medications for a viral infection when they are not needed. It contributes to the larger goal of disease management and eradication by being a useful tool for epidemiological research and vaccine development.

What are the growth prospects and trends in the dengue testing industry?

At present, the rising occurrence of dengue cases around the world due to lack of effective vector control represents one of the crucial factors impelling the market growth. Additionally, increasing advancements in diagnostic technologies, such as the development of rapid testing kits and point-of-care tests (POCT), are facilitating quicker and more accurate diagnoses. Besides this, the growing efforts to educate the public about the seriousness of dengue fever are offering a favorable market outlook.

In addition, the increasing collaboration between public and private entities for research and development (R&D) of better testing methods is supporting the market growth. Furthermore, the growing focus on combating vector-borne diseases, including dengue, by international bodies like the World Health Organization (WHO) is positively influencing the market. Apart from this, rising improvements in supply chain management are ensuring the easy availability of diagnostic kits and tools.

Additionally, the increasing integration of data analytics in healthcare to predict dengue outbreaks is contributing to the market growth. Moreover, the growing availability of medical supplies, including test kits, through online platforms is making it easier for healthcare providers to procure them.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/dengue-testing-market

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Test Type:
• ELISA-based Tests
• RT-PCR based Tests
• Dengue IgG/IgM Rapid Test
• Others

Breakup by End User:
• Hospitals
• Diagnostic Centers
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Some of the Top Key players in the Dengue Testing Market

Abbott Laboratories, Abnova Corporation, CerTest Biotec S.L., DiaSorin S.p.A., F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Other Reports:

Hadoop Big Data Analytics Market : https://www.linkedin.com/pulse/hadoop-big-data-analytics-market-size-report-forecast-vik-chauhan-rjlzf/

Identity Analytics Market : https://www.linkedin.com/pulse/identity-analytics-market-size-share-competitive-analysis-vik-chauhan-wk2gf/

Medical Coding Market : https://www.linkedin.com/pulse/global-medical-coding-market-size-industry-in-depth-analysis-chauhan-4rx9c/

Pharmacovigilance and Drug Safety Software Market : https://www.linkedin.com/pulse/pharmacovigilance-drug-safety-software-market-size-growth-vik-chauhan-qzwnc/

Surgical Imaging Market : https://www.linkedin.com/pulse/surgical-imaging-market-revenue-report-trends-growth-drivers-chauhan-wdeff/

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.